Oak Harbor Wealth Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$468K Sell
3,356
-48
-1% -$6.72K 0.11% 147
2025
Q4
$418K Buy
3,404
+48
+1% +$5.83K 0.1% 150
2025
Q3
$373K Hold
3,356
0.09% 154
2025
Q2
$372K Hold
3,356
0.1% 154
2025
Q1
$376K Hold
3,356
0.11% 145
2024
Q4
$310K Sell
3,356
-1
-0% -$90 0.09% 142
2024
Q3
$281K Buy
3,357
+2
+0.1% +$153 0.08% 144
2024
Q2
$230K Buy
3,355
+3
+0.1% +$200 0.07% 150
2024
Q1
$246K Buy
3,352
+2
+0.1% +$154 0.08% 150
2023
Q4
$271K Hold
3,350
0.09% 141
2023
Q3
$251K Sell
3,350
-123
-4% -$9.46K 0.09% 138
2023
Q2
$268K Sell
3,473
-37
-1% -$2.95K 0.09% 145
2023
Q1
$291K Sell
3,510
-226
-6% -$18.7K 0.11% 132
2022
Q4
$321K Buy
3,736
+1
+0% +$79 0.12% 120
2022
Q3
$230K Buy
3,735
+2
+0.1% +$126 0.09% 139
2022
Q2
$231K Sell
3,733
-200
-5% -$12.4K 0.09% 135
2022
Q1
$234K Buy
3,933
+200
+5% +$12.8K 0.08% 151
2021
Q4
$271K Buy
+3,733
New +$257K 0.09% 144

Other funds holding GILD

Oak Harbor Wealth Partners's GILD Position: Q1 2026 in Review

Oak Harbor Wealth Partners reduced its Gilead Sciences (GILD) stake by 1.4% in Q1 2026, selling an estimated $6.72K and leaving 3,356 shares worth $468K. The position accounts for 0.11% of the portfolio, ranked #147.

Oak Harbor Wealth Partners first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Oak Harbor Wealth Partners held 3,356 shares of Gilead Sciences worth $468K as of Q1 2026.
  • Oak Harbor Wealth Partners sold 48 Gilead Sciences shares in Q1 2026, an estimated $6.72K.
  • Gilead Sciences made up 0.11% of Oak Harbor Wealth Partners's portfolio in Q1 2026, its #147 holding.
  • Oak Harbor Wealth Partners first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Oak Harbor Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.